October 20, 2022 | |
Please join us for the November Lunch and Learn as Rivkin Radler Partners John Diviney and Tamika Hardy discuss the following topics:
- New State laws – New York Marijuana Regulation and Taxation Act, New York Labor Law Section 201-D, New York Human Rights Law, New York Penal Law, New York City Administrative Code
May 16, 2022 |
Ullman was cited in the Natural Products Insider article “Lawyers skeptical FDA warning letters will chill delta-8 THC market.”
The article discusses the effect of the recent rash of FDA warning letters on delta-8 THC products. The warning letters note that delta-8 THC is not an approved treatment for medical conditions.
Asked whether the warningRead More
April 26, 2022 | |
Marc Ullman was quoted in the Natural Products Insider article, “FDA written enforcement discretion on CBD unlikely.”
The article discusses how the FDA is unlikely to issue a formal policy of enforcement discretion for CBD-containing products marketed as dietary supplements.
Ullman doesn’t believe the agency would issue a CBD enforcement discretion policy similar to NAC.Read More
October 22, 2021 | |
Tamika Hardy was quoted in the Newsday article, “Employers can no longer test most job seekers for marijuana, NY says.”
New York legalized recreational marijuana earlier this year and now, most employers cannot penalize employees for off-hour marijuana use.
Hardy stated, “With certain exceptions, they can’t test employees for cannabis, either, under recent Department ofRead More
July 22, 2021 | |
On July 21, 2021, Tamika Hardy spoke at the Employment & NY Marijuana Legalization (MRTA) panel, presented by the Brooklyn branch of the NAACP.
The Brooklyn NAACP’s Justice Reform and Legal Redress Committees discussed the New York legalization of cannabis as it relates to employment.
Hardy discussed what recreational cannabis legalization means in the employmentRead More
March 29, 2021 | |
Steven Shapiro was quoted in the Vitamin Retailer article, “FDA Warns Selling of Topical CBD Products Violates FD&C Act.”
The FDA has issued warning letters to two companies addressing the illegal marketing of unapproved drugs labeled as containing CBD.
Shapiro questions the letters as neither discussed the potential to use CBD as an inactive ingredientRead More
October 6, 2020 |
On September 30, Marc Ullman spoke at the Natural Products Insider webinar “Hemp Evolution: Surviving the imminent regulatory shockwave.”
The presentation discussed mitigating legal risks and thriving in the multi-billion dollar hemp phytocannabinoid market.
The video is still available to view. Click here to register and watch.Read More
August 26, 2020 | |
Marc Ullman was quoted in a NutraIngredients-USA article, “AHPA event aims to guide CBD industry.”
The article discusses how products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.
Click here to read the full article.Read More
August 21, 2020 | |
Marc Ullman was quoted in a NutraIngredients USA article, “Upcoming event aims to help fill regulatory holes in hemp/CBD industry.”
The article discusses how CBD firms are often unprepared for the regulatory compliance side of operating a dietary supplement firm. The upcoming event that is being discussed in the article looks to assist with that.Read More
July 20, 2020 | | |
On August 27, Marc Ullman will be presenting at the American Herbal Products Association (AHPA) Hemp-CBD Supplement Virtual Congress. The seminar will provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market.
Click here to register.Read More
- Business Dissolution
- Commercial Litigation
- Complex Torts & Product Liability
- Compliance Investigations & White Collar
- Directors & Officers Liability
- Diversity & Inclusion
- Employment & Labor
- General Liability
- Health Services
- Insurance Coverage
- Insurance Fraud
- Intellectual Property
- Medical Malpractice Defense
- Privacy, Data & Cyber Law
- Professional Liability
- Real Estate, Zoning & Land Use
- Trusts & Estates